Treatment of pulmonary hypertension: bench to bedside

Heritable pulmonary hypertension: from bench to bedside.

Mutations in the BMPR2 gene, and more rarely in ACVRL1, endoglin, caveolin-1, KCNK3 and TBX4 genes predispose to heritable pulmonary arterial hypertension, an autosomal dominant disease with incomplete penetrance. Bi-allelic mutations in the EIF2AK4 gene predispose to heritable pulmonary veno-occlusive disease/pulmonary capillary haemangiomatosis, an autosomal recessive disease with an unknown ...

From bench to bedside

Because the microcirculation has emerged as an important reanimation target, appropriate methods to monitor the microcirculatory function are crucial. Several teams have now succeeded in crossing this bridge from bench to bedside, but the choice of the tissues of interest remains a debate. The potential accessible vascular beds that doctors could use in reanimation strategies and the relationsh...

Bench to bedside review

From Bench to Bedside

Since the initial experiments nearly a decade ago, remarkable progress has been made in the field of vascular gene transfer, and trials with human subjects already are under way. The potential of vascular wall gene transfer as therapy for various vascular diseases is considerable.1,2 The purpose of this review is 2-fold: (1) to delineate the methods and principles underlying vascular gene trans...

Asthma: bench to bedside

P108 Table Variable Asthmatic (n = 34) Mean (95% CI) Inflammatory (n = 20) Mean (95% CI) Non-inflammatory (n = 18) Mean (95% CI) Overall ANOVA Age (years) 49.9 (43.6 to 56.1) 54.1 (45.9 to 62.2) 50.2 (45.7 to 54.6) 0.577 Duration rhinitis (years) 15.9 (11.5 to 20.4) 14.3 (6.3 to 22.3) 17.7 (10.3 to 25.0) 0.773 Exhaled NO (ppb)* 34.3 (25.9 to 45.3) 48.2 (36.0 to 64.5) 15.4 (11.1 to 21.3) ,0.005 ...